Maximizing Therapeutic Succes: Choosing the Right Oligonucleotide, Delivery Vehicle & Administration Route
Time: 12:00 pm
day: Conference Day Two
Details:
- Shuttle peptide platform: Efficient endosomal escape driving the development of PMO-based therapeutics
- Development of a non-surgical therapeutic for basal cell carcinoma administered by intralesional injection
- Efficient delivery to airway epithelial cells, advancing inhaled PMO therapies for muco-obstructive lung diseases
Speakers:
